Article ID Journal Published Year Pages File Type
2574799 Vascular Pharmacology 2008 6 Pages PDF
Abstract

Hearts from Sprague–Dawley rats were perfused at constant flow and then exposed to 30 min global zero-flow ischemia followed by 15 min reperfusion. After ischemia–reperfusion, coronary arteries were dissected from the heart and segments 2 mm long were prepared for isometric tension recording in organ baths. Stimulation of the arteries with 5-hydroxytryptamine (10− 6 M) produced contraction, which was potentiated by treatment with endothelin-1 (3 × 10− 10; 10− 9 M). This potentiation was lower in the arteries from hearts after ischemia–reperfusion (for 3 × 10− 10 M, 15 ± 5%; P > 0.05; for 10− 9 M, 37 ± 7%, P < 0.01, n = 5) than after control (for 3 × 10− 10 M, 34 ± 4%; P < 0.01; for 10− 9 M, 50 ± 6%, P < 0.01, n = 5), and the potentiation was reduced by the inhibitor of nitric oxide synthesis l-NAME (10− 4 M), the antagonist of endothelin ETA receptors BQ123 (10− 6 M) and the antagonist of endothelin ETB receptors BQ788 (10− 6 M), but not by the cyclooxygenase inhibitor meclofenamate (10− 5 M). These results suggest that endothelin-1 at low concentrations potentiates coronary vasoconstriction, and this effect is reduced after ischemia–reperfusion, mediated by endothelin ETA and ETB receptors and dependent on nitric oxide release.

Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Authors
, , , , , ,